| Announce Date | 10/09/2025 |
| EPS Normalized Actual | $-0.00022 (Beat by $0.02978) |
| EPS GAAP Actual | $-0.00022 (Beat by $0.02978) |
| Revenue Actual | $0.209501B |
| Revenue Surprise | Beat by $209.501M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 0.0411657 | 29.72 | 0.03864358 | 0.04371966 | 1 |
| May 2029 | 0.16351 | 7.48 | 0.15223 | 0.17808 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | -0.0003 | -0.0003 | 0.209501B | 4.51% | 209.5M |
| FQ2 2025 (May 2025) | -1.3 | -1.3 | 0.224535B | 67.97% | 224.54M |
| FQ1 2025 (Feb 2025) | -0.87 | -0.87 | 0.18578B | -1.38% | 185.78M |
| FQ4 2024 (Nov 2024) | -0.0986 | -0.0986 | 0.21095B | 8.14% | 210.95M |
| FQ3 2024 (Aug 2024) | -0.0437 | -0.0437 | 0.200044B | 11.54% | 200.04M |
| FQ2 2024 (May 2024) | 0 | 0 | 0.071919B | -156.1% | 71.92M |
| FQ1 2024 (Feb 2024) | -0.0001 | -0.0001 | 0.18834B | 22.7% | 188.34M |
| FQ4 2023 (Nov 2023) | -0.07 | -0.07 | 0.193771B | 100% | 193.77M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0 | -- | 0 | 0 | 1 |
| FQ1 2028 (Feb 2028) | 0 | -- | 0 | 0 | 1 |
| FQ4 2027 (Nov 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Aug 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (May 2027) | -0.014444 | -- | -0.01687196 | -0.01312722 | 1 |
| FQ1 2027 (Feb 2027) | -0.043332 | -- | -0.043332 | -0.043332 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.35B | -- | 0.32B | 0.39B | 3 |
| FQ1 2028 (Feb 2028) | 0.22B | -- | 0.21B | 0.25B | 3 |
| FQ4 2027 (Nov 2027) | 0.25B | -- | 0.23B | 0.28B | 4 |
| FQ3 2027 (Aug 2027) | 0.24B | -- | 0.22B | 0.27B | 4 |
| FQ2 2027 (May 2027) | 0.27B | -- | 0.25B | 0.31B | 4 |
| FQ1 2027 (Feb 2027) | 0.23B | -- | 0.23B | 0.23B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | -0.0003 | -0.0003 | 100% | |
| FQ2 2025 (May 2025) | -1.3 | -1.3 | 100% | |
| FQ1 2025 (Feb 2025) | -0.87 | -0.87 | 100% | |
| FQ4 2024 (Nov 2024) | -0.0986 | -0.0986 | 100% | |
| FQ3 2024 (Aug 2024) | -0.0437 | -0.0437 | 100% | |
| FQ2 2024 (May 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Feb 2024) | -0.0001 | -0.0001 | 100% | |
| FQ4 2023 (Nov 2023) | -0.07 | -0.07 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0B | $0.21B | $209.5M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.22B | $224.54M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.19B | $185.78M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.21B | $210.95M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.2B | $200.04M | 100% |
| FQ2 2024 (May 2024) | $0B | $0.07B | $71.92M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $0.19B | $188.34M | 100% |
| FQ4 2023 (Nov 2023) | $0B | $0.19B | $193.77M | 100% |